Guest Contributors

Lon Cardon Lon Cardon, Ph.D., Chief Scientific Officer at BioMarin Pharmaceutical	Andrew Carroll Andrew Carroll, VP of Science at DNAnexus	Brian Caveney Brian Caveney, President and CMO at Labcorp
Mark Chaisson Assistant Professor at University of Southern California	Chapman, Rowan, PhD Partner, Mohr Davidow	Alka Chaubey Alka Chaubey, CMO, Bionano Genomics
Chen, Roger CSO, Genia Technologies	Noam Chomsky Professor of Linguistics, MIT	Deanna Church
Church, George, PhD Professor of Genetics, Harvard Medical School	Erik Clausen Managing Partner and VP of Public Relations, Chempetitive Group	Kenneth Cole Kenneth Cole, Group Leader, Bioassay Methods Biosystems and Biomaterials Division
Sam Colella Co-Founder, Versant Ventures	Viswa Colluru Viswa Colluru, Founder & CEO at Enveda Biosciences	Comfort, Nathaniel, PhD Professor, History of Science, Technology and Medicine, Johns Hopkins University
Carolyn Compton Professor of Pathology, ASU	Conley, John, PhD Professor of Law, UNC School of Law	Laurence Cooper Pediatric Oncologist and Immunotherapy Researcher
Andrea Cossarizza Andrea Cossarizza, Professor of Pathology at the University of Modena and Reggio Emilia School of Medicine	Lee Cronin Lee Cronin, Regius Chair of Chemistry, University of Glasgow	Cruikshank, Greg Founder, BioConference Live
Cumbers, John, PhD Synthetic Biologist, NASA Ames	Christina Curtis Christina Curtis, Associate Professor of Oncology and Genetics at Stanford	Colleen Cutcliffe CEO, Whole Biome
Sugganth Daniel Sugganth Daniel, Director of Oncology Medical Affairs, Invitae